Prot#2689-CL-0011: A Phase 1 Study of AC220 (ASP2689) as Maintenance Therapy in Subjects With Acute Myeloid Leukemia Who Have Been Treated With an Allogeneic Hematopoietic Stem Cell Transplant

Project: Research project

Project Details

StatusFinished
Effective start/end date5/11/125/11/18

Funding

  • Astellas Pharma Global Development, Inc. (2689-CL-0011)